PetIQ (PETQ) Ownership - Who owns PetIQ?

16 days until earnings call

Profile

Industry
Pharmaceuticals Major
Address
230 East Riverside Drive
Phone
+1 208 939-8900
Employees
1933
Web
https://www.petiq.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
539.9M
P/E Ratio
264.14
Total Cash
116.37M
Projected Growth
1.58
Total Debt
468.3M
Revenue
1.1B
Risk (Beta)
1.98
Dividend Yield
N/A
Total Cash/Share
3.99
Total Debt/Equity
N/A
Revenue/Share
37.32 USD as % of share price

Fundamentals

PETQ
Capitalization
540M
P/E Ratio
264.14
Risk (Beta)
1.98
Dividend Yield
N/A
Total Cash
116M
Total Cash/Share
3.99
Total Debt
468M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
1.58
Revenue/Share (as % of the share price)
37.32%
Revenue
1.1B
ROE
N/A
Book Value
221M
P/B Ratio
2.44
Cash Flow
N/A
Earnings
0.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
29K
Current Ratio
2.27
Current Revenue Per Employee
113774.45
Dividends Per Share - Security
N/A
EBITDA
81.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
20.00
Revenue To Assets
0.25
Shares Held By Institutions
802M
Shares Outstanding - Current
29.2M
Total Liabilities
645M
Total Volume MTD
N/A
Value
-1
Gain YTD
8.203
View a ticker or compare two or three
PETQ
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of veterinarian-grade pet prescription medications

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
230 East Riverside Drive
Phone
+1 208 939-8900
Employees
1933
Web
https://www.petiq.com